Table 1.
Subject characteristics and risk factors.
| Demographics and risk factor | Mean ± SD or number of subjects, n | Range (if applicable) |
|---|---|---|
| Age, yrs | 67.8 ± 8.4 | 45–84 |
| Male, n | 16 (80%) | |
| BMI, kg/m2 | 30.6 ± 4.5 | 22.1–38.3 |
| Hypertension, n | 12 (60%) | |
| History of cardiovascular disease, n | 12 (60%) | |
| Coronary artery disease, n | 8 (40%) | |
| Stroke, n | 4 (20%) | |
| Transient ischemic attack, n | 1 (5%) | |
| Smoking status | ||
| Active, n | 4 (20%) | |
| Prior, n | 5 (25%) | |
| Never smoked, n | 11 (55%) | |
| Hyperlipidaemia, n | 17 (85%) | |
| Total cholesterol, mg/dL | 170.1 ± 41.3 | 120–263 |
| Triglycerides (TG), mg/dL | 175.3 ± 107.7 | 50–420 |
| HDL cholesterol, mg/dL | 46.9 ± 14.3 | 23–80 |
| LDL cholesterol, mg/dL | 89.1 ± 37.3 | 48–170 |
| Medication | ||
| Aspirin, n | 15 (75%) | |
| Statins, n | 18 (90%) | |
| Nitrates, n | 8 (40%) | |
| Beta blockers, n | 12 (60%) | |
| Calcium channel blockers, n | 5 (25%) | |
| ACEI, n | 8 (40%) | |
| Carotid stenosis | ||
| Severe (>70%), n | 1 (5%) | |
| Moderate (50–69%), n | 3 (15%) | |
| None/Mild (<50%), n | 16 (80%) | |